EMBO J 2000,19(20):5288–5299.PubMedCrossRef 29. Pappalardo L, Janausch IG, Vijayan V, Zientz E, Junker J, Peti W, Zweckstetter M, Unden G, Griesinger C: The NMR structure of the sensory domain of the membranous two-component fumarate sensor (histidine protein kinase) DcuS of Escherichia coli. J Biol Chem 2003,278(40):39185–39188.PubMedCrossRef 30. Zhulin IB, Nikolskaya AN, Galperin MY: Common extracellular sensory domains in transmembrane receptors for diverse signal transduction pathways in bacteria and archaea. J Bacteriol 2003,185(1):285–294.PubMedCrossRef 31. Anantharaman V, Aravind L: The CHASE domain: a predicted ligand-binding module in plant cytokinin

receptors and other eukaryotic see more and bacterial receptors. Trends Biochem Sci 2001,26(10):579–582.PubMedCrossRef 32. Gomelsky M, Klug G: BLUF: a novel FAD-binding domain involved in sensory transduction in microorganisms. Trends Biochem Sci 2002,27(10):497–500.PubMedCrossRef

33. Seshasayee AS, Fraser GM, Luscombe NM: Comparative genomics of cyclic-di-GMP signalling in bacteria: post-translational regulation and catalytic activity. Nucleic Acids Res 2010,38(18):5970–5981.PubMedCrossRef 34. Newell PD, Monds RD, O’Toole GA: LapD is a bis-(3′,5′)-cyclic dimeric GMP-binding protein that regulates surface attachment by Pseudomonas buy Roscovitine fluorescens Pf0–1. Proc Natl Acad Sci U S A 2009,106(9):3461–3466.PubMedCrossRef 35. Christen M, Christen B, Folcher M, Schauerte A, Jenal U: Identification and characterization of a cyclic di-GMP-specific phosphodiesterase and its allosteric control by GTP. J Biol Chem 2005,280(35):30829–30837.PubMedCrossRef 36. Grant JR, Stothard P: The CGView Server: a comparative genomics tool for circular genomes. Nucleic Acids Res 2008,36(Web Server issue):W181-W184.PubMedCrossRef 37. Dutta C, Pan A: Horizontal gene transfer and bacterial diversity. J Biosci 2002,27(1 Suppl 1):27–33.PubMedCrossRef 38. Cummings L, Riley L, Black L, Souvorov A, Resenchuk S, Dondoshansky I, Tatusova T: Genomic BLAST: custom-defined virtual Orotidine 5′-phosphate decarboxylase databases

for complete and unfinished genomes. FEMS Microbiol Lett 2002,216(2):133–138.PubMedCrossRef 39. Maglott D, Ostell J, Pruitt KD, Tatusova T: Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 2011,39(Database issue):D52-D57.PubMedCrossRef 40. Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott C, Fong JH, Geer LY, Geer RC, Gonzales NR, et al.: CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res 2011,39(Database issue):D225-D229.PubMedCrossRef 41. Zdobnov EM, Apweiler R: InterProScan–an integration platform for the signature-recognition methods in InterPro. Bioinformatics 2001,17(9):847–848.PubMedCrossRef 42. Finn RD, Mistry J, Tate J, Coggill P, Heger A, Pollington JE, Gavin OL, Gunasekaran P, Ceric G, Forslund K, et al.: The Pfam protein families database. Nucleic Acids Res 2010,38(Database issue):D211-D222.

By contrast, the contribution of rpoB carrying Q513L mutation Erlotinib clinical trial to RMP-resistance was not that evident. The insertion of this gene into an M. tuberculosis H37Ra laboratory strain did not result in a significant level of RMP-resistance, however the insertion of the same gene was responsible for resistance to RMP of two M. tuberculosis clinical strains (MIC 12.5 and 50 μg/ml) when used as hosts. As identified in various clinical studies, the level of RMP-resistance of M. tuberculosis isolates carrying the Q513L mutation varies from 2 to 200 μg/ml [14, 20, 21, 23, 38]. The collected results suggest that rpoB

carrying Q513L mutation is able to cause resistance to RMP only in selected tubercle bacilli. It is likely that this mutation can result in RMP-resistance

in strains with low cell wall permeability since this exclusion barrier is responsible for natural resistance of some MAIC strains [26, 27]. We also cannot exclude the possibility that other mechanisms support RMP-resistance of strains carrying Q513L mutation. The drug resistance of M. tuberculosis can be also connected to the overproduction of a drug target due to accumulation of point mutations in a promoter region [40–42]. To test whether overproduction of rpoB carrying a given mutation result in higher MIC for RMP compared to a strain expressing the same gene under control of the natural promoter, rpoB genes were cloned under control of the P hsp promoter and introduced into M. tuberculosis host. The P hsp promoter, commonly used in genetics studies of mycobacteria controlling the groEL gene (Rv0440) in M. tuberculosis, has already been Navitoclax clinical trial reported as highly active in mycobacterial cells growing in vitro [24, 25]. A recent microarray study showed that the expression level

of groEL in M. tuberculosis cells growing in log phase is high, but not higher than rpoB [43]. However, the arresting of M. tuberculosis growth results in 3.6-fold induction of groEL with a decrease of rpoB expression in the same conditions [44]. We have not observed higher RMP resistance next when mutated rpoB genes were expressed under control of P hsp promoter in comparison to the natural promoter. It is possible that the natural level of RpoB is high enough to saturate RMP (if its concentration in cell is low). On the other hand, the extra expression of rpoB cannot help in cells accumulating high RMP level. However, to elucidate this problem an alternative expression system and precise control of protein expression would be required. The natural resistance to RMP in some M. avium and M. intracellulare strains is known to be as a result of an efficient cell wall permeability and exclusion barrier [26, 27], suggesting that these elements may be also important in M. tuberculosis. Changes in cell wall composition could affect permeability [45] decreasing the intracellular concentration of drug.

Young’s modulus could not be properly calculated, as the effective area in a vertebra that contains trabecular buy Gemcitabine and cortical bone varies going from cranial to caudal ends. Therefore, secant stiffness was calculated for each recorded cycle by dividing the load range by the displacement range of that cycle. Initial secant stiffness was determined

at the start of the experiment, and final secant stiffness was determined at the time of failure. For each sample, time to failure, apparent strain at failure, steady-state creep rate, initial stiffness, and percent loss of stiffness at failure were calculated. Fig. 2 Three representative force–displacement cycles throughout the testing period: 20, 55, and 10,620 cycles for a typical sample. Force–displacement cycles display typical fatigue behavior characterized by BMS 907351 decreasing secant stiffness, increasing hysteresis, and increasing nonlinearity. Displacement increases over time due to mostly creep and to a lower extent, a decreasing secant stiffness Fig. 3 Typical sample for which creep characteristics

exhibit three typical phases of fatigue: an initial phase of high creep rate, a phase of a steady-state lower creep rate, and a phase in which creep rate is high again, finally resulting in failure [33, 40]. From each apparent strain against time curve, the creep rate of the secondary phase is determined by fitting a linear line. According to the method of Bowman et al. [33], a line parallel to this line is drawn at 0.5% higher offset. The intersection of this line RNA Synthesis inhibitor with the apparent strain curve is defined as the time to failure and the strain at failure Data analysis Pearson correlation coefficients were used to determine the relation between trabecular bone microarchitecture, cortical thickness, and compressive fatigue properties. For this, all structural properties were correlated with fatigue properties as well as

with log-transformed values of the fatigue properties. Also, all structural and fatigue parameters were compared between the two groups using a Student’s t test. p values below 0.05 were considered significant. Results During fatigue testing, 12 samples failed between 10 min and 14.7 h (1,200 and 106,000 cycles), and five samples did not fail within the studied period of time. The latter samples showed a decreasing, rather than an increasing, apparent strain range per cycle during the test, accompanied by an increasing secant stiffness, suggesting that artifacts were present in these tests [41]. These samples were subsequently removed from all analyses in the study, resulting in seven samples in the SHAM-OVX and five in the OVX-ZOL group. Trabecular and cortical microarchitecture No significant differences were found in trabecular bone microarchitecture and cortical thickness between the SHAM-OVX- and the OVX-ZOL-treated group except for Tb.

Only in the group of patients with higher hs-CRP levels (≥0.3 mg/dl) were both IL-6 Selleck GSK458 and ferritin significant predictors of hepcidin by multivariate analysis. We therefore assume that the expression of hepcidin-25 is principally associated with ferritin in stable MHD patients without apparent inflammatory disease [8]. Thus, the

serum hepcidin level is principally modulated by iron stores, which in turn are generally reflected by the serum ferritin level [49]. The relationship between serum ferritin and iron storage has been investigated, and the expression of ferritin was exclusively dependent on iron, even in patients with ACD [49]. Fig. 2 Correlation between serum ferritin and hepcidin levels (a), percent nonheme iron absorption (b), and percent early iron release from macrophages (c). a Serum ferritin levels are significantly correlated with serum hepcidin levels in both healthy volunteers and MHD patients (recalculated from the relationships depicted in the study by Kuragano et al. [8, 45]) (log[hepcidin] = 0.72 × log[ferritin (ng/ml)] − 0.17; r = 0.64; P < 0.01). b A highly significant inverse correlation is observed between serum ferritin and the percentage of absorbed nonheme iron in healthy volunteers (log[nonheme iron absorption (%)] = −0.84 × log[ferritin (ng/ml)] + 2.07; r = 0.82; P < 0.001 [8, 54]). c Serum ferritin levels are significantly correlated with early iron release derived from senescent

red blood cells of the reticuloendothelial system in healthy subjects and in patients with iron deficiency, inflammation, MLN0128 clinical trial marrow aplasia, and hyperplastic erythropoiesis, respectively. Patients with hemochromatosis have been excluded from the analysis because they may have defects in hepcidin synthesis. The calculation of early release of radiolabeled-iron from the reticuloendothelial system is based on the rate of 55Fe transferrin clearance and the reappearance of transferrin 59Fe derived from radiolabeled heat-damaged red blood cells. (log[early iron release(%)] = −0.28 × log[ferritin (ng/ml)] +2.32; r = 0.86; P < 0.001; [58]) Recent reports have confirmed that iron

stores are the major determinant of serum hepcidin levels as well as iron mobilization. In rats and humans with ACD, serum hepcidin concentrations are elevated, and this is paralleled by reduced duodenal and macrophage Erastin chemical structure expression of FPN. The coexistence of ACD and iron deficiency anemia (IDA) results in a smaller increase in hepcidin expression. Correspondingly, individuals with ACD/IDA have significantly lower hepcidin levels than patients with ACD alone. Moreover, ACD/IDA patients, in contrast to ACD subjects, were found to be able to absorb dietary iron from the gut and mobilize iron from macrophages. These data again demonstrate that circulating hepcidin levels are mainly dependent on iron stores and perturbed iron traffic, even in the presence of ACD [50].

Nevertheless, as the sequencing accuracy of all next generation sequencing methods decreases at the 3′ end of the reads [19], overlapping of the pair end sequencing reads with 5′ end sequences obviously increases the accuracy of Natural Product Library purchase the final result. Furthermore, we employed a very stringent pipeline to trim the low quality reads, as we removed all tags with mismatches in the overlapped

region, mismatches with primers, having any N bases, and very short tags. The large number of tags showing mismatches with primers (52,016) had two resources: (i) the impurity of the primers during primer synthesis; and (ii) sequencing error. We suggest that the first one could be the major reason as the quality checking of the primer using mass spectrum showed that there could be nearly 10% of impure primers in the ultra PAGE purified primers (Additional file 3). We found that removing tags with any N bases was very critical, as the 23,222 tags with N bases formed 16,397 unique sequences. Considering that the final number of unique tags was only 67,826, the tags with N bases could contribute a large number of novel unique click here sequences, but only as singletons or doubletons, therefore to increase the diversity estimation. Although we

may not preclude the sequencing artifacts existing in the final result, we suppose that sequencing error effect has been minimized at the present time and we could explore the PCR effect on the 16 S rRNA deep sequencing methods. Effect of polymerase The polymerase showed significant

effect on both the taxa richness and community structure analysis in our result. Qiu et al. (2001) compared three enzymes with different processitivity and fidelity. They found that the AmpliTaq showed the lowest number PCR artifacts, but not the enzymes with higher fidelity or processitivity. In our study, the two tested polymerases were high fidelity enzymes. The PfuUltra II Fusion HS DNA Hydroxychloroquine cell line Polymerase was suggested to have the highest fidelity (20 fold higher than the conventional Taq) and enhanced processitivity (Stratagene manual). The Ex Taq (Takara) had a 4 fold higher fidelity than the conventional Taq. The rarefaction curves of PfuUltra II at the unique distance showed much lower slopes than that of the Ex Taq, indicating that less PCR artifacts were produced using the PfuUltra II enzymes. In addition, while the determined sequences were grouped into 0.03 OTUs, the slopes of rarefaction curves of the two groups showed less pronounced differences, suggesting that a number of the different tags between the two groups could be PCR artifacts, as PCR mutants were suggested to be within 97% similarity with the original sequence [9]. A more important finding of the present study was that the two enzymes showed different community structures, besides different rRNA microbial richness.

706 0.386 1.291 0.258 Resection margin 1.138 0.574 2.258 0.711 Discussion In this study, expression of three CTAs at protein level was investigated by immunohistochemistry. MAGE-A1, MAGE-A3/4 and NY-ESO-1 were selected considering that these antigens have been well-accredited and are being applied for clinical trials of vaccine immunotherapy [15–18]. The

expression frequency of CTAs varies greatly in different tumors type [19, 20]. Our results showed that expression rates of MAGE-A1, MAGE-A3/4 and NY-ESO-1 in IHCC were less than 30%. According to the established criteria [21], IHCC should be classified to be low “”CTA expressors”". In a previous study, the expression rates of MAGE-A1, MAGE-A3 and NY-ESO-I in

IHCC were 20.0% (4/20), 20.0% (4/20) and 10.0% (2/20) detected by RT-PCR [6]. However, in the VX-809 purchase immunohistochemical study by Tsuneyama et al. [7], 32 of 68 IHCC cases (47.1%) demonstrated positive MAGE-A3 expression using a polyclonal antibody. These discrepancies between our and previous studies may be related to the difference in the method of detection, the antibodies adopted and patient populations. In this study, we also identified that only MAGE-3/4 and at least one positive CTA expression correlated aggressive phenotypes including bigger tumor size and higher recurrence rate. There was no other association observed between CTA markers (either individual or combined) with Belinostat cell line HLA class I expression and clinicopathological parameters of IHCC patients. Curves of patients with positive for the individual or multiple CTAs (with two or three CTA positive) markers leaned Morin Hydrate towards a poorer outcome, however, only MAGE-A3/4 reach statistical significance. We speculated that such statistically insignificant trends were likely to be due to the fact that only a small number of IHCC cases presented with positive CTA expression (either individual or co-expressed) in this study. Considering that combination of CTAs makers may reinforce the predictive value for prognosis and malignant phonotype by one single CTA alone, we next asked whether at least one CTA expression

had n significant impact on outcome. We found that at least one CTA expression did indeed correlate with a significantly poorer survival. Furthermore, at least one positive CTA expression was also an independent prognostic factor for patients with IHCC. Interestingly, in this study, MAGE-A1 and NY-ESO-1 positive IHCC tumors seem to have a relatively higher frequency of positive expression of HLA class I than MAGE-A3/4 positive cases. Recently, Kikuchi et al. [22] indicated that co-expression of CTA (XAGE-1b) and HLA class I expression may elicit a CD8+ T-cell response against minimal residual disease after surgery and resulted in prolonged survival of NSCLC patients, while expression of CTA combined with down-regulated HLA class I expression correlated with poor survival.

Biofilm assay EHEC biofilms were grown in polystyrene

96-well plates by plating 200 μl/well of 100 fold diluted overnight cultures in presence of 6.25, 12.5, 50, or 100 μg/ml of limonoids at 26°C for 24 h without shaking [23, 39]. For VS138 (ΔqseC) and VS179 (VS138 + qseBC) biofilms were quantified after 48 h growth in 96-well plates. The biofilms were quantified by staining with 0.3% crystal violet (Fisher, Hanover Park, IL) for 20 min. Extra stain was washed with phosphate buffer (0.1 M, pH 7.4) and dye associated with attached biofilm was dissolved with DMSO. An absorbance at 570 nm was used to quantify the total biofilm mass. In vitro adhesion assay Human epithelial Caco-2 cells were purchased from ATCC (Manassas, VA) and maintained in selleck products Dulbecco’s Minimal Essential Medium (DMEM) learn more with nonessential amino acids and 10% fetal bovine serum without antibiotics. Caco-2 cells

were seeded at 1 × 105 cells/well in 6-well plates and infected with approximately 5 × 106 cells/well of freshly grown EHEC ATCC 43895 in presence or absence of 100 μg/ml isolimonic acid, ichangin, isoobacunoic acid, IOAG and DNAG. The plates were incubated for 3 h at 37°C in 5% CO2 environment. After completion of incubation, plates were washed 3× with sterile PBS to remove any loosely attached cells. Caco-2 cells were lysed with 0.1% Triton-X in PBS to release the bacteria and serial dilutions were plated on LB-agar and incubated at 37°C for 24 h. Colonies were counted after incubation period and presented as log10CFU/ml. Caco-2 cell survival assay Caco-2 cells (1 × 104/well) were seeded in 96-well plate and exposed to 100 μg/ml of isolimonic acid, ichangin, isoobacunoic Nintedanib order acid, IOAG and DNAG for 6 h in humidified incubator at 5% CO2, 37°C. Cell survival was determined by measuring lactate dehydrogenase using CytoTox-ONE™ Homogeneous Membrane Integrity Assay (Promega Corp., Madison, WI). Quantitative PCR Relative transcript amount of selected genes (Table 2) was measured by qRT-PCR as described [23]. Briefly, overnight cultures of EHEC ATCC 43895 were diluted 100 fold with fresh LB medium or DMEM+10% FBS (referred as DMEM henceforth),

treated with limonoids (100μg/ml) or DMSO and grown further at 37°C, 200 rpm. Bacterial cells were collected at OD600 ≈1.0. RNA was extracted using RNeasy minikit (Qiagen Inc., Valencia CA) and converted to cDNA using MuLV reverse transcriptase enzyme and random hexamer in a Reverse-Transcriptase polymerase chain reaction (RT-PCR) [43] at 42°C for 1 h. PCR products were purified with QIAquick PCR-purification kit (Qiagen Inc.). Twenty five nanogram cDNA from each sample was amplified with 10 pmol target primers using SYBR Green PCR master mix (Life Technologies Corporation, Carlsbad, CA) for 40 amplification cycles. After completion of 40 PCR cycles, melt curve data was generated. All the measurements were done on three biological replicates consisting of three technical replicates each.

A discrete Gamma distribution was used to model evolutionary rate differences among sites (5 categories (+G, parameter = 0.5355)). The tree is drawn to scale, with branch lengths measured

in the number of substitutions per site. Nucleotide sequences (16S rDNA) from 30 species were aligned. After removing all positions containing gaps and missing data, the final dataset included 1136 positions.Evolutionary analyses were conducted Selleck R788 in MEGA5 [10]. The number in parentheses indicates the number of plasmids previously described for each species. No indication means that there is no reported evidence of plasmid in these species. For M. mycoides subsp. capri, each one of the three plasmids was identified in a different strain. The letters on the right side of the figure indicate the phylogenetic groups within the Mollicutes: S, Spiroplasma; H: Hominis; P: Pneumoniae; AP: Acholeplasma-Phytoplasma; M: Mycoplasma mycoides cluster. The present work was conducted in order to better comprehend the nature and extend of the plasmid repertoire of two main groups of ruminant mycoplasmas: the M. agalactiae-M.

bovis group and the species found within or close to the M. mycoides cluster, two Temsirolimus molecular weight phylogenetically distant groups between which a high level of HGT has been predicted in silico [4] (Figure 1). Several plasmids were isolated from various species and completely sequenced. Comparative analyses indicated that, except

for the recently described pMyBK1 from M. yeatsii[25], all plasmids belong to the same large family of rolling-circle replicons found in Firmicutes. Plasmid pMYBK1 represents a new family of replicons that can be transformed and maintained in other mycoplasma species. The study further indicates that plasmids can be commonly found in several Mycoplasma species colonizing ruminants and therefore, could contribute to the genetic transfers that have been revealed by comparative genomics. Methods Mycoplasma strains, PIK3C2G growth conditions and DNA purification All mycoplasma strains used in this study (Table 1) are kept in the collection maintained by the Anses laboratory of Lyon and most of them were isolated as part of the activities of the Vigimyc network [26]. They were cultivated at 37°C in Mycoplasma broth base supplemented as for SP4 medium [27]. Mycoplasma transformants were sub-cultured in modified Hayflick broth [28] supplemented with 0.4% (w/v) pyruvate, 0.2% (w/v) glucose and 5–15 μg of tetracycline mL-1. Spiroplasma citri was grown at 32°C in SP4 broth withoutfresh yeast extract. Escherichia coli DH10B was used as the host strain in cloning experiments and was grown in LB medium supplemented with 100 μg.ml-1 of ampicillin for selection. Table 1 Mycoplasma plasmids analyzed in this study Taxon Strain name Plasmid name Reference GenBank access n° Plasmid size M. leachii 99/0361 pBG7AU Djordjevik et al.

Biochim Biophys Acta 990:87–92CrossRef Gorsuch PA, Pandey S, Atkin OK (2010) Temporal heterogeneity of cold acclimation phenotypes in Arabidopsis leaves. Plant Cell Environ 33:244–258PubMedCrossRef Hancock AM, Panobinostat chemical structure Brachi B, Faure N, Horton MW, Jarimowycz LB, Sperone FG, Toomajian C, Roux F, Bergelson J (2011) Adaptation to climate across the Arabidopsis thaliana genome. Science 334:83–86PubMedCrossRef

Hidema J, Makino A, Mae T, Ojima K (1991) Photosynthetic characteristics of rice leaves aged under different irradiances from full expansion through senescence. Plant Physiol 97:1287–1293PubMedCrossRef Hikosaka K (1997) Modeling optimal temperature acclimation of the photosynthetic apparatus in C3 plants with respect

to nitrogen use. Ann Bot 80:721–730CrossRef Hikosaka K (2005) Nitrogen partitioning in the photosynthetic apparatus of Plantago asiatica leaves grown under different temperature and light conditions: similarities and differences between temperature and ICG-001 in vitro light acclimation. Plant Cell Physiol 46:1283–1290PubMedCrossRef Hikosaka K, Terashima I (1995) A model of the acclimation of photosynthesis in the leaves of C3 plants to sun and shade with respect to nitrogen use. Plant Cell Environ 18:605–618CrossRef Hikosaka K, Terashima I (1996) Nitrogen partitioning among photosynthetic components and its consequence in sun and shade plants. Funct Ecol 10:335–343CrossRef Hikosaka K, Murakami A, Hirose T (1999) Balancing carboxylation and regeneration of ribulose-1,5-bisphosphate in leaf photosynthesis temperature acclimation of an evergreen tree, Quercus myrsinaefolia. Plant Cell Environ Docetaxel mw 22:841–849CrossRef Hikosaka K, Ishikawa K, Borjigidai A, Muller O, Onoda Y (2006) Temperature acclimation of photosynthesis: mechanisms involved in the changes in temperature dependence of photosynthetic rate. J Exp Bot 57:291–302PubMedCrossRef Huner NPA, Oquist G, Sarhan F (1998) Energy balance and acclimation to light and cold. Trends Plant Sci 3:224–230CrossRef

Inskeep WP, Bloom PR (1985) Extinction coefficients of chlorophyll a and b in N,N-dimethylformamide and 80 % acetone. Plant Physiol 77:483–485PubMedCrossRef Ishikawa K, Onoda Y, Hikosaka K (2007) Intraspecific variation in temperature dependence of gas exchange characteristics among Plantago asiatica ecotypes from different temperature regimes. New Phytol 176:356–364PubMedCrossRef Kirschbaum MUF, Farquhar GD (1984) Temperature dependence of whole-leaf photosynthesis in Eucalyptus pauciflora Sieb. ex Spreng. Aust J Plant Physiol 11:519–538CrossRef Koornneef M, Alonso-Blanco C, Vreugdenhil D (2004) Naturally occurring genetic variation in Arabidopsis thaliana. Annu Rev Plant Biol 55:141–172PubMedCrossRef Leuning R (1997) Scaling to a common temperature improves the correlation between the photosynthesis parameters Jmax and VCmax.

We analyzed the bacteria in a culture grown with 3,4-dihydroxypyridine by PCR-DGGE (Figure 6A). The culture completely degraded 3,4-dihydroxypyridine during 4 days of cultivation. Among the dominant bacteria, strain 4AP-A grew well in the 3,4-dihydroxypyridine medium and completely degraded 3,4-dihydroxypyridine during 3 days of cultivation. Strain 4AP-G grew slowly and degraded the substrate in 7 days. In the DGGE gels, several bands, including that of strain 4AP-A, were present; the band corresponding to strain 4AP-Y was absent; and a new band appeared. The sequence ITF2357 cell line of the 16S rRNA gene of the bacterium corresponding to the new band, strain 4AP-Z, showed a high level of identity with

those of Elizabethkingia spp. (GU084120 and AY468482). We also analyzed the bacteria in a culture grown with formate by PCR-DGGE (Figure 6B). In the DGGE gels, several bands, including that of strain Y, were present. Figure 6 DGGE profiles of the enrichment culture grown in medium containing 4-aminopyridine, 3,4-dihydroxypyridine, or formate. The enrichment culture grown in medium containing 4-aminopyridine

was used to inoculate medium Anti-infection Compound Library cell line containing 0.9 mM 3,4-dihydroxypyridine or 2.13 mM formate and 0.43 mM ammonium chloride. The culture was incubated and subcultured in fresh medium twice before DGGE analysis. (A) The standard amplified fragments from strains 4AP-A, 4AP-B, 4AP-C, 4AP-D, 4AP-E, 4AP-F, and 4AP-G were loaded in lane M. Lane 1, culture grown in medium

containing 4-aminopyridine; lane 2, culture grown in medium containing 3,4-dihydroxypyridine. (B) The standard amplified fragments from the seven strains; lane 1, culture grown in medium containing formate and ammonium chloride; lane 2, culture grown in medium in the absence of formate. Extraction of genomic DNA and preparation of DGGE samples were carried out Carnitine palmitoyltransferase II in triplicate. Prominent DNA bands from the DGGE gels were extracted and used as PCR templates as described in the text. Discussion The pyridine-ring hydroxylation step is one of main initial steps in the degradation of pyridines [4]. Our analyses of the accumulated metabolites from 4-aminopyridine and the growth substrate specificity suggested that 4-aminopyridine was converted to 4-amino-3-hydroxypyridine and 3,4-dihydroxypyridine (Figure 1). We hypothesized that 4-hydroxypyridine is another possible metabolite based on the previously reported metabolic pathways of pyridines [3]. The enrichment culture could not degrade 4-amino-3-hydroxypyridine and 4-hydroxypyridine, even when 4-aminopyridine was added to the medium. Therefore, 4-amino-3-hydroxypyridine must be a dead-end product. In the enrichment culture, 4-aminopyridine probably would be directly converted to 3,4-dihydroxypyridine mainly by dehydroxylation and the release of ammonia (Figure 1), similar to the conversion of aniline to benzenediol (catechol) by a dioxygenase [27].